A Lower Allred Score for Progesterone Receptor Is Strongly Associated With a Higher Recurrence Score of 21-Gene Assay in Breast Cancer

Does oncotype DX recurrence score affect the management of patients with early-stage breast cancer?

(2008) Juhi Asad et al.   AMERICAN JOURNAL OF SURGERY

Tissue microarray technology in the routine assessment of HER-2 status in invasive breast cancer: a prospective study of the use of immunohistochemistry and fluorescence in situ hybridization

(2008) A D Graham et al.   HISTOPATHOLOGY

Molecular classifications of breast carcinoma with similar terminology and different definitions: are they the same?

(2008) Ping Tang et al.   HUMAN PATHOLOGY

Bone metastasis is strongly associated with estrogen receptor–positive/progesterone receptor–negative breast carcinomas

(2008) Bing Wei et al.   HUMAN PATHOLOGY

Prognostic Utility of the 21-Gene Assay in Hormone Receptor–Positive Operable Breast Cancer Compared With Classical Clinicopathologic Features

(2008) Lori J. Goldstein et al.   JOURNAL OF CLINICAL ONCOLOGY

Breast Cancer Subtype Approximated by Estrogen Receptor, Progesterone Receptor, and HER-2 Is Associated With Local and Distant Recurrence After Breast-Conserving Therapy

(2008) Paul L. Nguyen et al.   JOURNAL OF CLINICAL ONCOLOGY

Histopathologic variables predict Oncotype DX™ Recurrence Score

(2008) Melina B Flanagan et al.   MODERN PATHOLOGY

Association between standard clinical and pathologic characteristics and the 21-gene recurrence score in breast cancer patients

(2007) Ido Wolf et al.   CANCER